Insurance - Property & Casualty
Compare Stocks
5 / 10Stock Comparison
AII vs HCI vs UPC vs HRTG vs ALL
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Property & Casualty
Drug Manufacturers - Specialty & Generic
Insurance - Property & Casualty
Insurance - Property & Casualty
AII vs HCI vs UPC vs HRTG vs ALL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Property & Casualty | Insurance - Property & Casualty | Drug Manufacturers - Specialty & Generic | Insurance - Property & Casualty | Insurance - Property & Casualty |
| Market Cap | $378M | $2.00B | $2M | $888M | $56.10B |
| Revenue (TTM) | $276M | $902M | $41M | $842M | $67.14B |
| Net Income (TTM) | $87M | $299M | $-12M | $149M | $12.14B |
| Gross Margin | 52.1% | 63.3% | 30.3% | 35.7% | 39.8% |
| Operating Margin | 35.0% | 47.6% | -26.7% | 24.9% | 23.3% |
| Forward P/E | 6.8x | 9.3x | — | 6.2x | 8.0x |
| Total Debt | $4M | $67M | $9M | $141M | $7.49B |
| Cash & Equiv. | $173M | $1.21B | $34M | $453M | $678M |
AII vs HCI vs UPC vs HRTG vs ALL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 25 | May 26 | Return |
|---|---|---|---|
| American Integrity … (AII) | 100 | 116.5 | +16.5% |
| HCI Group, Inc. (HCI) | 100 | 91.3 | -8.7% |
| Universe Pharmaceut… (UPC) | 100 | 60.0 | -40.0% |
| Heritage Insurance … (HRTG) | 100 | 117.4 | +17.4% |
| The Allstate Corpor… (ALL) | 100 | 103.8 | +3.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AII vs HCI vs UPC vs HRTG vs ALL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AII is the #2 pick in this set and the best alternative if dividends is your priority.
- 3.2% yield, 2-year raise streak, vs ALL's 1.8%, (2 stocks pay no dividend)
HCI carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 20.2%, EPS growth 179.8%, 3Y rev CAGR 22.3%
- 451.6% 10Y total return vs HRTG's 131.2%
- Lower volatility, beta 0.39, Low D/E 6.0%, current ratio 145.90x
- PEG 0.19 vs ALL's 0.47
Among these 5 stocks, UPC doesn't own a clear edge in any measured category.
HRTG ranks third and is worth considering specifically for momentum.
- +44.8% vs UPC's -36.9%
ALL is the clearest fit if your priority is income & stability.
- Dividend streak 12 yrs, beta 0.12, yield 1.8%
- Beta 0.12 vs UPC's 1.26
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.2% revenue growth vs UPC's -22.4% | |
| Value | PEG 0.19 vs 0.47 | |
| Quality / Margins | 33.2% margin vs UPC's -30.3% | |
| Stability / Safety | Beta 0.12 vs UPC's 1.26 | |
| Dividends | 3.2% yield, 2-year raise streak, vs ALL's 1.8%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +44.8% vs UPC's -36.9% | |
| Efficiency (ROA) | 12.5% ROA vs UPC's -18.6%, ROIC 6.8% vs -7.8% |
AII vs HCI vs UPC vs HRTG vs ALL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
AII vs HCI vs UPC vs HRTG vs ALL — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HCI leads in 2 of 6 categories
UPC leads 1 • HRTG leads 1 • ALL leads 1 • AII leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HCI leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ALL is the larger business by revenue, generating $67.1B annually — 1642.2x UPC's $41M. HCI is the more profitable business, keeping 33.2% of every revenue dollar as net income compared to UPC's -30.3%. On growth, HCI holds the edge at +52.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $276M | $902M | $41M | $842M | $67.1B |
| EBITDAEarnings before interest/tax | $99M | $441M | -$10M | $222M | $16.0B |
| Net IncomeAfter-tax profit | $87M | $299M | -$12M | $149M | $12.1B |
| Free Cash FlowCash after capex | $236M | $442M | -$15M | $110M | $11.5B |
| Gross MarginGross profit ÷ Revenue | +52.1% | +63.3% | +30.3% | +35.7% | +39.8% |
| Operating MarginEBIT ÷ Revenue | +35.0% | +47.6% | -26.7% | +24.9% | +23.3% |
| Net MarginNet income ÷ Revenue | +31.6% | +33.2% | -30.3% | +17.7% | +18.1% |
| FCF MarginFCF ÷ Revenue | +85.5% | +49.0% | -37.2% | +13.0% | +17.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +52.5% | -14.1% | +0.3% | +4.2% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +40.9% | -100.1% | +5.0% | +3.4% |
Valuation Metrics
UPC leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 5.7x trailing earnings, ALL trades at a 60% valuation discount to HRTG's 14.3x P/E. Adjusting for growth (PEG ratio), HCI offers better value at 0.13x vs HRTG's 0.92x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $378M | $2.0B | $2M | $888M | $56.1B |
| Enterprise ValueMkt cap + debt − cash | $208M | $860M | -$23M | $576M | $62.9B |
| Trailing P/EPrice ÷ TTM EPS | 9.95x | 6.20x | -0.00x | 14.29x | 5.71x |
| Forward P/EPrice ÷ next-FY EPS est. | 6.83x | 9.27x | — | 6.22x | 8.03x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.13x | — | 0.92x | 0.33x |
| EV / EBITDAEnterprise value multiple | 3.87x | 1.95x | — | 6.25x | 4.61x |
| Price / SalesMarket cap ÷ Revenue | 1.85x | 2.22x | 0.09x | 1.09x | 0.84x |
| Price / BookPrice ÷ Book value/share | 2.33x | 1.78x | 0.00x | 3.03x | 1.89x |
| Price / FCFMarket cap ÷ FCF | 2.56x | 4.51x | — | 11.26x | 5.68x |
Profitability & Efficiency
HCI leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ALL delivers a 42.7% return on equity — every $100 of shareholder capital generates $43 in annual profit, vs $-27 for UPC. AII carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to HRTG's 0.49x. On the Piotroski fundamental quality scale (0–9), HCI scores 8/9 vs UPC's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +27.6% | +36.2% | -27.0% | +41.4% | +42.7% |
| ROA (TTM)Return on assets | +6.1% | +12.5% | -18.6% | +6.2% | +10.1% |
| ROICReturn on invested capital | +107.5% | +6.8% | -7.8% | — | +29.8% |
| ROCEReturn on capital employed | +5.4% | +18.1% | -5.6% | +3.6% | +29.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 8 | 4 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.02x | 0.06x | 0.16x | 0.49x | 0.24x |
| Net DebtTotal debt minus cash | -$170M | -$1.2B | -$24M | -$311M | $6.8B |
| Cash & Equiv.Liquid assets | $173M | $1.2B | $34M | $453M | $678M |
| Total DebtShort + long-term debt | $4M | $67M | $9M | $141M | $7.5B |
| Interest CoverageEBIT ÷ Interest expense | — | 47.89x | -22.11x | 23.95x | 40.22x |
Total Returns (Dividends Reinvested)
HRTG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HRTG five years ago would be worth $33,472 today (with dividends reinvested), compared to $2 for UPC. Over the past 12 months, HRTG leads with a +44.8% total return vs UPC's -36.9%. The 3-year compound annual growth rate (CAGR) favors HRTG at 91.5% vs UPC's -89.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +0.7% | -16.0% | -32.2% | +5.3% | +7.4% |
| 1-Year ReturnPast 12 months | +20.3% | +5.8% | -36.9% | +44.8% | +9.9% |
| 3-Year ReturnCumulative with dividends | +20.3% | +212.1% | -99.9% | +602.2% | +97.5% |
| 5-Year ReturnCumulative with dividends | +20.3% | +110.5% | -100.0% | +234.7% | +78.0% |
| 10-Year ReturnCumulative with dividends | +20.3% | +451.6% | -100.0% | +131.2% | +265.6% |
| CAGR (3Y)Annualised 3-year return | +6.4% | +46.1% | -89.5% | +91.5% | +25.5% |
Risk & Volatility
ALL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ALL is the less volatile stock with a 0.12 beta — it tends to amplify market swings less than UPC's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALL currently trades 98.1% from its 52-week high vs UPC's 25.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.49x | 0.39x | 1.26x | 0.50x | 0.12x |
| 52-Week HighHighest price in past year | $26.36 | $210.50 | $11.00 | $31.98 | $222.22 |
| 52-Week LowLowest price in past year | $15.77 | $136.37 | $2.00 | $16.83 | $188.08 |
| % of 52W HighCurrent price vs 52-week peak | +73.3% | +73.2% | +25.7% | +89.8% | +98.1% |
| RSI (14)Momentum oscillator 0–100 | 54.6 | 49.7 | 51.5 | 58.2 | 57.4 |
| Avg Volume (50D)Average daily shares traded | 119K | 166K | 8K | 283K | 1.2M |
Analyst Outlook
Evenly matched — AII and ALL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AII as "Buy", HCI as "Buy", HRTG as "Buy", ALL as "Buy". Consensus price targets imply 45.0% upside for AII (target: $28) vs -17.9% for HCI (target: $127). For income investors, AII offers the higher dividend yield at 3.18% vs HCI's 0.97%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | — | Buy | Buy |
| Price TargetConsensus 12-month target | $28.00 | $126.50 | — | $39.00 | $244.38 |
| # AnalystsCovering analysts | 5 | 14 | — | 9 | 44 |
| Dividend YieldAnnual dividend ÷ price | +3.2% | +1.0% | — | +0.0% | +1.8% |
| Dividend StreakConsecutive years of raises | 2 | 2 | 2 | 1 | 12 |
| Dividend / ShareAnnual DPS | $0.61 | $1.50 | — | $0.00 | $3.91 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.1% | 0.0% | +0.0% | +2.2% |
HCI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). UPC leads in 1 (Valuation Metrics). 1 tied.
AII vs HCI vs UPC vs HRTG vs ALL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AII or HCI or UPC or HRTG or ALL a better buy right now?
For growth investors, HCI Group, Inc.
(HCI) is the stronger pick with 20. 2% revenue growth year-over-year, versus -22. 4% for Universe Pharmaceuticals Inc. (UPC). The Allstate Corporation (ALL) offers the better valuation at 5. 7x trailing P/E (8. 0x forward), making it the more compelling value choice. Analysts rate American Integrity Insurance Group, Inc. (AII) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AII or HCI or UPC or HRTG or ALL?
On trailing P/E, The Allstate Corporation (ALL) is the cheapest at 5.
7x versus Heritage Insurance Holdings, Inc. at 14. 3x. On forward P/E, Heritage Insurance Holdings, Inc. is actually cheaper at 6. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: HCI Group, Inc. wins at 0. 19x versus The Allstate Corporation's 0. 47x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — AII or HCI or UPC or HRTG or ALL?
Over the past 5 years, Heritage Insurance Holdings, Inc.
(HRTG) delivered a total return of +234. 7%, compared to -100. 0% for Universe Pharmaceuticals Inc. (UPC). Over 10 years, the gap is even starker: HCI returned +451. 6% versus UPC's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AII or HCI or UPC or HRTG or ALL?
By beta (market sensitivity over 5 years), The Allstate Corporation (ALL) is the lower-risk stock at 0.
12β versus Universe Pharmaceuticals Inc. 's 1. 26β — meaning UPC is approximately 991% more volatile than ALL relative to the S&P 500. On balance sheet safety, American Integrity Insurance Group, Inc. (AII) carries a lower debt/equity ratio of 2% versus 49% for Heritage Insurance Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AII or HCI or UPC or HRTG or ALL?
By revenue growth (latest reported year), HCI Group, Inc.
(HCI) is pulling ahead at 20. 2% versus -22. 4% for Universe Pharmaceuticals Inc. (UPC). On earnings-per-share growth, the picture is similar: HCI Group, Inc. grew EPS 179. 8% year-over-year, compared to 5. 4% for American Integrity Insurance Group, Inc.. Over a 3-year CAGR, HCI leads at 22. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AII or HCI or UPC or HRTG or ALL?
HCI Group, Inc.
(HCI) is the more profitable company, earning 33. 2% net margin versus -20. 6% for Universe Pharmaceuticals Inc. — meaning it keeps 33. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCI leads at 47. 7% versus -16. 3% for UPC. At the gross margin level — before operating expenses — HCI leads at 73. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AII or HCI or UPC or HRTG or ALL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, HCI Group, Inc. (HCI) is the more undervalued stock at a PEG of 0. 19x versus The Allstate Corporation's 0. 47x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Heritage Insurance Holdings, Inc. (HRTG) trades at 6. 2x forward P/E versus 9. 3x for HCI Group, Inc. — 3. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AII: 45. 0% to $28. 00.
08Which pays a better dividend — AII or HCI or UPC or HRTG or ALL?
In this comparison, AII (3.
2% yield), ALL (1. 8% yield), HCI (1. 0% yield) pay a dividend. UPC, HRTG do not pay a meaningful dividend and should not be held primarily for income.
09Is AII or HCI or UPC or HRTG or ALL better for a retirement portfolio?
For long-horizon retirement investors, The Allstate Corporation (ALL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
12), 1. 8% yield, +265. 6% 10Y return). Both have compounded well over 10 years (ALL: +265. 6%, UPC: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AII and HCI and UPC and HRTG and ALL?
These companies operate in different sectors (AII (Financial Services) and HCI (Financial Services) and UPC (Healthcare) and HRTG (Financial Services) and ALL (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: AII is a small-cap deep-value stock; HCI is a small-cap high-growth stock; UPC is a small-cap quality compounder stock; HRTG is a small-cap deep-value stock; ALL is a mid-cap deep-value stock. AII, HCI, ALL pay a dividend while UPC, HRTG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.